Your browser doesn't support javascript.
loading
Fibroblast matrix implants-a better alternative for incisional hernia repair?
Hendrawan, Siufui; Lheman, Jennifer; Weber, Ursula; Oberkofler, Christian Eugen; Eryani, Astheria; Vonlanthen, René; Baer, Hans Ulrich.
Afiliação
  • Hendrawan S; Tarumanagara Human Cell Technology Laboratory, Faculty of Medicine, Tarumanagara University, Jakarta 11440, Indonesia.
  • Lheman J; Department of Biochemistry and Molecular Biology, Faculty of Medicine, Tarumanagara University, Jakarta 11440, Indonesia.
  • Weber U; Tarumanagara Human Cell Technology Laboratory, Faculty of Medicine, Tarumanagara University, Jakarta 11440, Indonesia.
  • Oberkofler CE; Tarumanagara Human Cell Technology Laboratory, Faculty of Medicine, Tarumanagara University, Jakarta 11440, Indonesia.
  • Eryani A; Baermed, Centre of Abdominal Surgery, Hirslanden Clinic, 8032 Zürich, Switzerland.
  • Vonlanthen R; Vivévis AG, Viszeral-, Tumor- und Roboterchirurgie, Kappelistrasse 7, 8002 Zürich, Switzerland.
  • Baer HU; Department of Histology, Faculty of Medicine, Tarumanagara University, Jakarta 11440, Indonesia.
Biomed Mater ; 19(3)2024 Apr 25.
Article em En | MEDLINE | ID: mdl-38604155
ABSTRACT
The standard surgical procedure for abdominal hernia repair with conventional prosthetic mesh still results in a high recurrence rate. In the present study, we propose a fibroblast matrix implant (FMI), which is a three-dimensional (3D) poly-L-lactic acid scaffold coated with collagen (matrix) and seeded with fibroblasts, as an alternative mesh for hernia repair. The matrix was seeded with fibroblasts (cellularized) and treated with a conditioned medium (CM) of human Umbilical Cord Mesenchymal Stem Cells (hUC-MSC). Fibroblast proliferation and function were assessed and compared between treated with CM hUC-MSC and untreated group, 24 h after seeding onto the matrix (n= 3). To study the matricesin vivo,the hernia was surgically created on male Sprague Dawley rats and repaired with four different grafts (n= 3), including a commercial mesh (mesh group), a matrix without cells (cell-free group), a matrix seeded with fibroblasts (FMI group), and a matrix seeded with fibroblasts and cultured in medium treated with 1% CM hUC-MSC (FMI-CM group).In vitroexamination showed that the fibroblasts' proliferation on the matrices (treated group) did not differ significantly compared to the untreated group. CM hUC-MSC was able to promote the collagen synthesis of the fibroblasts, resulting in a higher collagen concentration compared to the untreated group. Furthermore, thein vivostudy showed that the matrices allowed fibroblast growth and supported cell functionality for at least 1 month after implantation. The highest number of fibroblasts was observed in the FMI group at the 14 d endpoint, but at the 28 d endpoint, the FMI-CM group had the highest. Collagen deposition area and neovascularization at the implantation site were observed in all groups without any significant difference between the groups. FMI combined with CM hUC-MSC may serve as a better option for hernia repair, providing additional reinforcement which in turn should reduce hernia recurrence.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Telas Cirúrgicas / Colágeno / Ratos Sprague-Dawley / Proliferação de Células / Alicerces Teciduais / Células-Tronco Mesenquimais / Herniorrafia / Fibroblastos / Hérnia Incisional Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Telas Cirúrgicas / Colágeno / Ratos Sprague-Dawley / Proliferação de Células / Alicerces Teciduais / Células-Tronco Mesenquimais / Herniorrafia / Fibroblastos / Hérnia Incisional Idioma: En Ano de publicação: 2024 Tipo de documento: Article